JusticeItaly Official institution
Italy changes the official sales permission for Apixaban Viatris Pharma
Italy's medicines agency, AIFA, has published a notice that changes the marketing authorization for Apixaban Viatris Pharma, a human medicine containing apixaban. Marketing authorization is the official permission that allows a medicine to be sold. The notice is filed under reference 26A05649, but the excerpt does not say what the change is.
This summary was generated by AI; the official source prevails.
What does it mean?
Italy's medicine regulator has officially changed the permission under which the blood-thinning medicine Apixaban Viatris Pharma is sold. Apixaban is a blood thinner, a medicine that makes blood clot more slowly. The short notice does not say what was changed.